Health Canada — Medical Devices · Canada · 2019-07-19 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Some Beckman Coulter customers have reported quality control (QC) failure on the AQUIOS system when performing testing with the affected lot. Beckman Coulter has confirmed through internal testing of this product lot that the system may include a significant portion of the monocyte population in the lymphocyte region during automated data analysis due to insufficient separation of the two populations in the side scatter vs. CD45 plot.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.